ONC-783 Clinical Trials (2026): 1 Studies for Advanced Solid Tumor
Hipa.ai Research · Source: ClinicalTrials.gov / AACT
Synced daily from ClinicalTrials.gov via AACT. Last sync: .
1 ONC-783 clinical trials are catalogued on Hipa.ai from the AACT mirror of ClinicalTrials.gov, spanning 1 indication (including Advanced Solid Tumor) and 20 total planned enrollment. 1 ONC-783 clinical trial is actively recruiting at 2 U.S. sites across 2 states. Most recent activity: NCT07408258 (Aug 2028).
Where to Participate: All ONC-783 Trial Sites in the U.S. (2 sites across 2 states)
Every actively recruiting ONC-783trial site, sorted by state then city. Each row links to the trial detail page (eligibility, contacts, full study record). Sites no longer enrolling at the location level are excluded. ClinicalTrials.gov / AACT does not provide street-level addresses; the map link uses the facility's geocoded coordinates where available.
| State | Facility | City | Trial | Map |
|---|---|---|---|---|
| NY | Columbia University Medical Center | New York10032 | NCT07408258 | Map |
| TX | MD Anderson Cancer Center | Houston77030 | NCT07408258 | Map |
ONC-783 clinical trials at a glance: phase × recruitment status
| Phase | recruiting | Total |
|---|---|---|
| P1 | 1 | 1 |
Recruiting ONC-783 clinical trials (1)
Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).
| NCT ID | Title | Phase | Indication | Enrollment | Started |
|---|---|---|---|---|---|
| NCT07408258 | PKSafety, Pharmacokinetics (PK), and Efficacy of ONC-783 in Advanced Solid Tumors | P1 | Advanced Solid Tumor | 20 | Aug 2026 |
All ONC-783 trials (1)
Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.
| NCT ID | Acronym | Title | Phase | Status | Enrollment | Sponsor | Started |
|---|---|---|---|---|---|---|---|
| NCT07408258 | PK | Safety, Pharmacokinetics (PK), and Efficacy of ONC-783 in Advanced Solid Tumors | P1 | recruiting | 20 | OncoC4, Inc. | Aug 2026 |
ONC-783 clinical trials: frequently asked questions
- How many ONC-783 clinical trials are there?
- 1 ONC-783 clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 1 is actively recruiting participants.
- Are ONC-783 clinical trials recruiting in 2026?
- Yes — 1 ONC-783 trial is actively recruiting in 2026, with 2 U.S. sites across 2 states. See the recruiting trials and the per-state site list further down this page.
- What conditions is ONC-783 being studied for?
- ONC-783 is being studied for Advanced Solid Tumor. The trials are grouped by indication on this page.
- What phase is ONC-783 in?
- ONC-783 clinical trials span 1 Phase 1. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.
- Who sponsors ONC-783 clinical trials?
- The lead sponsor across the most ONC-783 trials is OncoC4, Inc.. Each trial row links to the full study detail page including sponsor information.
Sources and methodology
Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming ONC-783as an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.
Last refreshed .
Related pages on Hipa.ai: